Interventional Cardiology Devices Market Is Anticipated To Reach USD 25.16 bn By 2020: By Grand View Research, Inc.
The global interventional cardiology devices market is
expected to reach USD 25.16 billion by 2020, according to a new report by Grand
View Research. Increasing prevalence of cardiovascular diseases coupled with
adoption of minimally invasive surgeries is expected to boost the
interventional cardiology device market over the forecast period. Unhealthy
lifestyle habits such as high alcohol consumption, smoking, and lack of
physical exercise are triggering incidences of cardiovascular diseases.
Furthermore, the number of congenital heart disease patients is on a constant
rise and this acts as a growth driver for the market.
Browse full research report Interventional Cardiology
Devices Market: http://www.grandviewresearch.com/industry-analysis/interventional-cardiology-devices-market-analysis
According to a report published by the U.S. CDC (Centers for
Disease Control and Prevention) in 2011, congenital heart defects are the most
common birth defects in the U.S., affecting approximately 1% of the births
every year. The treatment of cardiovascular disorders has changed dramatically
due to the introduction of new drug therapies and devices such as guidewires
and stents allowing the patient to live better quality and longer lives.
The advent of technologically advanced internal substitutes
plays an integral role in this market and manufacturers focus on developing new
products to curb problems associated with previous versions. For example, the
evolution of stents began from bare metal stents and has now reached a
completely new horizon in the form of disappearing stents (bio-absorbable
stents). Stents accounted for over 70% market share primarily owing to high
usage rates in 2013.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Catheters in sync with stent are expected to register steady
growth to reach up to a market size of over USD 2.5 billion in 2020. The growth
is primarily driven by primarily the rising demand for minimally invasive
medical procedures in the field of cardiovascular diseases. Faster patient
recovery time and lesser procedure duration are two most significant factors
contributing towards the rising demand of these medical procedures.
The North America interventional cardiology device market in
2013 was valued at over USD 5.5 billion, owing to factors such as the presence
of favorable government initiatives encouraging new product development,
sophisticated healthcare infrastructure and increasing patient awareness levels
coupled with relatively higher healthcare expenditures in the region.
On the other hand, the Asia Pacific market is expected to
reach over USD 6.4 billion by 2022, growing at a lucrative rate over the
forecast period. The growth is attributed to the presence of large untapped
opportunities, rising healthcare expenditure, cardiovascular disease incidence
rate, and disposable income levels. Prominent players operating in this
industry includes Cordis Corporation, Abbott Laboratories, Medtronic, Inc,
Terumo Medical Corporation, B. Braun Melsungen AG, and Boston Scientific.
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/interventional-cardiology-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment